» Articles » PMID: 15096660

Prevention of Diabetic Nephropathy by Treatment with Astaxanthin in Diabetic Db/db Mice

Overview
Journal Biofactors
Publisher IOS Press
Specialty Biochemistry
Date 2004 Apr 21
PMID 15096660
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is implicated as an important mechanism by which diabetes causes nephropathy. Astaxanthin, which is found as a common pigment in algae, fish, and birds, is a carotenoid with significant potential for antioxidative activity. In this study, we examined whether chronic administration of astaxanthin could prevent the progression of diabetic nephropathy induced by oxidative stress in mice. We used female db/db mice, a rodent model of type 2 diabetes, and their non-diabetic db/m littermates. The mice were divided into three groups as follows: non-diabetic db/m, diabetic db/db, and diabetic db/db treated with astaxanthin. Blood glucose level, body weight, urinary albumin, and urinary 8-hydroxydeoxyguanosine (8-OHdG) were measured during the experiments. Histological and 8-OHdG immunohistochemical studies were performed for 12 weeks from the beginning of treatment. After 12 weeks of treatment, the astaxanthin-treated group showed a lower level of blood glucose compared with the non-treated db/db group; however, both groups had a significantly high level compared with the db/m mice. The relative mesangial area calculated by the mesangial area/total glomerular area ratio was significantly ameliorated in the astaxanthin-treated group compared with the non-treated db/db group. The increases in urinary albumin and 8-OHdG at 12 weeks of treatment were significantly inhibited by chronic treatment with astaxanthin. The 8-OHdG immunoreactive cells in glomeruli of non-treated db/db mice were more numerous than in the astaxanthin-treated db/db mice. In this study, treatment with astaxanthin ameliorated the progression and acceleration of diabetic nephropathy in the rodent model of type 2 diabetes. The results suggested that the antioxidative activity of astaxanthin reduced the oxidative stress on the kidneys and prevented renal cell damage. In conclusion, administration of astaxanthin might be a novel approach for the prevention of diabetes nephropathy.

Citing Articles

Investigation of the Effect of Astaxanthin on Autophagy in Renal Ischemia-reperfusion Modeled Rats.

Kisaoglu A, Kose E, Yilmaz N, Tanbek K, Yildiz A, Yilmaz U Medeni Med J. 2024; 39(2):101-108.

PMID: 38940481 PMC: 11572265. DOI: 10.4274/MMJ.galenos.2024.27243.


The protective effects of flavonoids and carotenoids against diabetic complications-A review of evidence.

Jin Y, Arroo R Front Nutr. 2023; 10:1020950.

PMID: 37032781 PMC: 10080163. DOI: 10.3389/fnut.2023.1020950.


The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential.

Wang S, Qi X Front Pharmacol. 2022; 13:916653.

PMID: 35814201 PMC: 9263351. DOI: 10.3389/fphar.2022.916653.


Pharmacological agents for the prevention of colistin-induced nephrotoxicity.

Mirjalili M, Mirzaei E, Vazin A Eur J Med Res. 2022; 27(1):64.

PMID: 35525994 PMC: 9077985. DOI: 10.1186/s40001-022-00689-w.


Antioxidant effects of astaxanthin and metformin combined therapy in type 2 diabetes mellitus patients: a randomized double-blind controlled clinical trial.

Rad N, Movahedian A, Feizi A, Aminorroaya A, Aarabi M Res Pharm Sci. 2022; 17(2):219-230.

PMID: 35280834 PMC: 8860106. DOI: 10.4103/1735-5362.335179.